Evommune, Inc. (EVMN)
NYSE: EVMN · Real-Time Price · USD
25.51
-3.14 (-10.96%)
At close: Apr 10, 2026, 4:00 PM EDT
25.80
+0.29 (1.14%)
After-hours: Apr 10, 2026, 7:21 PM EDT
Evommune Market Cap
Evommune has a market cap or net worth of $918.83 million as of April 10, 2026.
Market Cap
918.83M
Enterprise Value
771.69M
1-Year Change
n/a
Ranking
Category
Stock Price
$25.51
Market Cap Chart
Since the IPO on November 6, 2025, Evommune's market cap has increased from $481.24M to $918.83M, an increase of 90.93%. That is a compound annual growth rate of 358.57%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 10, 2026 | 918.83M | 70.25% |
| Dec 31, 2025 | 539.69M | 12.15% |
| Nov 6, 2025 | 481.24M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| GH Research | 975.10M |
| uniQure | 961.70M |
| CytomX Therapeutics | 949.02M |
| Annexon | 938.77M |
| Aktis Oncology | 933.06M |
| Compass Therapeutics | 931.05M |
| Xencor | 910.87M |
| Janux Therapeutics | 908.22M |